Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis
ACS Applied Materials & Interfaces · 26.06.2024 · 16 (25) · 31950-31965
DOI: 10.1021/acsami.4c02914 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 11.06.2024. Verfasst von Yuqin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Melanins, Nanoparticles, Probiotics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a recurrent chronic mucosal inflammation disease whose most significant pathological characteristics are intestinal inflammation and damaged mucosal barrier induced by reactive oxygen/nitrogen species, abnormal immune microenvironment, and intestinal microecological imbalance. Oral probiotics are a living therapy for intestinal diseases, but their clinical application is hindered by poor bacterial biological activity and insufficient intestinal retention. Here, we developed a targeted oral formulation, functionalized probiotic Lf@MPB, with Lactobacillus fermentum (Lf) as the core and modified melanin nanoparticles (MNPs) on its surface through a click reaction of tricarboxyphenylboronic acid for synergistic therapy of UC. In vitro experiments showed that Lf@MPB not only possessed strong free radical scavenging ability, reduced cellular mitochondrial polarization, and inhibited apoptosis but also significantly enhanced the viability of Lf probiotics in simulated gastrointestinal fluid. Fluorescence imaging in vivo revealed the high accumulation of Lf@MPB at the site of intestinal inflammation in dextran sulfate sodium-induced UC mice. Moreover, in vivo results demonstrated that Lf@MPB effectively alleviated oxidative stress and inflammatory response and restored the intestinal barrier. In addition, 16S rRNA gene sequencing verified that Lf@MPB could increase the abundance and diversity of intestinal microbial communities and optimize microbial composition to inhibit the progression of UC. This work combines effective antioxidant and anti-inflammatory strategies with the oral administration of functionalized probiotics to provide a promising alternative for UC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, China.
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.
- Shanxi Medical University, Taiyuan 030001, China.
- First Hospital of Shanxi Medical University, Taiyuan 030001, China.
- The Radiology Department of Shanxi Provincial People's Hospital, Five Hospital of Shanxi Medical University, Taiyuan 030001, China.
ORCID-Profile: Jinghua Sun, Ruiping Zhang
Förderung
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Shanxi Province
Zitieren
APA
Liu, Y., Gao, C., Li, G., Niu, Z., Liu, X., Shen, H., Sun, J., & Zhang, R. (2024). Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis. ACS Applied Materials & Interfaces, 16(25), 31950-31965. https://doi.org/10.1021/acsami.4c02914
Vancouver
Liu Y, Gao C, Li G, Niu Z, Liu X, Shen H, et al. Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis. ACS Applied Materials & Interfaces. 2024;16(25):31950-31965. doi:10.1021/acsami.4c02914
BibTeX
@article{Liu2024,
author = {Liu, Yuqin and Gao, Caifang and Li, Gang and Niu, Zhuangzhuang and Liu, Xiaoli and Shen, Hao and Sun, Jinghua and Zhang, Ruiping},
title = {Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {25},
pages = {31950--31965},
doi = {10.1021/acsami.4c02914}
}
EUVIMED